DRUGS & THERAPY PERSPECTIVES is an esteemed journal published by SpringerNature, dedicated to advancing knowledge in the field of pharmacology and therapeutic studies. With an ISSN of 1172-0360 and an E-ISSN of 1179-1977, this journal has been providing valuable insights since its inception in 1993 and continues to publish until 2024. Ranked in the Q3 category for Pharmacology (medical) and positioned within the 25th percentile according to Scopus rankings, it serves as a vital resource for researchers, practitioners, and students alike. Although it is not an open-access journal, it offers a comprehensive platform for innovative research, clinical practices, and evolving therapeutic strategies, reflecting the critical developments in drug therapy landscape. With its strategic emphasis on bridging academic studies and clinical applications, DRUGS & THERAPY PERSPECTIVES remains essential for those committed to enhancing drug efficacy and patient outcomes in the ever-evolving medical field.

Current Geriatrics Reports is a pivotal journal published by SPRINGER, dedicated to disseminating cutting-edge research and insights in the dynamic field of geriatrics and gerontology. Launched in 2014 and ongoing until 2024, this journal plays a critical role in addressing the complex needs and challenges faced by the aging population. Although it currently holds a Q4 quartile ranking in its category and occupies the 84th position out of 116 in the Scopus metrics for Medicine, Geriatrics, and Gerontology, it serves as a vital platform for emerging research that shapes clinical practices and policy-making. Researchers, professionals, and students alike will find Current Geriatrics Reports to be an invaluable resource for staying updated on advancements, best practices, and innovations in geriatric care. While the journal is not open access, it continues to impact the field significantly and enrich contemporary discussions surrounding aging.

ACTA PHARMACEUTICA is a distinguished open-access journal published by SCIENDO, dedicated to advancing knowledge in the fields of medicine and pharmaceutical sciences. Established in 1992, the journal has made significant contributions to the scholarly community, providing a platform for innovative research and discussion. With a strong presence in both Q2 and Q3 quartiles across various categories including Pharmaceutical Science and Pharmacology, ACTA PHARMACEUTICA ranks favorably, positioning its contributions in the upper tiers of the field. The journal's commitment to open access since 2007 ensures that both practitioners and scholars have immediate access to cutting-edge developments, thereby fostering collaboration and knowledge sharing. With its scope spanning a broad spectrum of pharmaceutical and biomedical research, ACTA PHARMACEUTICA is an essential resource for researchers, professionals, and students keen to stay abreast of the latest advancements and trends in these vital areas of study.

Aging Medicine and Healthcare is a leading Open Access journal dedicated to advancing the understanding of geriatric health and the complexities of aging. Published by the Asia Pacific League Clinical Gerontology & Geriatrics, this innovative journal began its journey in 2019 and has since established itself as an important resource for healthcare professionals, researchers, and students interested in the fields of geriatrics and gerontology. With an impact factor that reflects its growing significance (ranked in the 21st percentile within its category), the journal aims to disseminate high-quality research and practical insights that can inform clinical practice and enhance patient care for aging populations. As an Open Access publication, it ensures that research findings are freely accessible, fostering collaboration and knowledge sharing among academics and practitioners globally. The journal is poised to be a vital platform for innovative studies, systematic reviews, and case reports that illuminate the challenges and opportunities in aging medicine.

The Turkish Journal of Geriatrics (Türk Geriatri Dergisi), with ISSN 1304-2947 and E-ISSN 1307-9948, is a distinguished scholarly publication dedicated to the field of geriatrics and gerontology, proudly published by the Turkish Geriatrics Society. Established to foster knowledge and research in the aging population, this journal plays a crucial role in disseminating significant findings and advancements in the medical care of elderly individuals. Since its inception in 1998, the journal has committed to high-quality, peer-reviewed articles that explore diverse aspects of geriatric medicine, contributing vital insights to practitioners and researchers alike. Although it currently holds a Q4 ranking in the category of Geriatrics and Gerontology, the Turkish Journal of Geriatrics is on an upward trajectory, making it an essential resource for those specializing in the care of older adults. Researchers and professionals are encouraged to explore its rich archive and benefit from the open-access publishing model, promoting broader access to impactful research. For those invested in the well-being of the elderly, the Turkish Journal of Geriatrics serves not only as a platform for scholarly communication but also as a catalyst for innovation in geriatric care.

Journal of Frailty & Aging, published by SPRINGER BASEL AG, is a leading platform dedicated to advancing research in the fields of aging, geriatrics, and gerontology. With an ISSN of 2260-1341 and an E-ISSN of 2273-4309, this journal has established itself as a pivotal resource for scholars and practitioners aiming to explore the complexities of frailty and its impact on aging populations. As of 2023, it proudly holds a Q3 classification in Aging and Q2 classifications in both Geriatrics and Gerontology, as well as Physiology (medical), alongside a notable Q1 ranking in Medicine (miscellaneous). The journal's Scopus ranks further reflect its quality and relevance, with rankings as high as #22 in Aging within the Biochemistry, Genetics and Molecular Biology category. The Journal of Frailty & Aging invites contributions that illuminate contemporary challenges and innovations in the field, offering Open Access to enhance the dissemination of knowledge. By publishing rigorous research and impactful reviews, the journal strives to foster a deeper understanding of health and well-being in older adults, making it an essential resource for researchers, healthcare professionals, and students engaged in this vital area of study.

Canadian Geriatrics Journal, published by MULTIMED INC, is a prominent platform dedicated to advancing the field of geriatrics and gerontology. With its esteemed status as a Q2 journal in both Geriatrics and Gerontology categories for 2023, it ranks favorably within the academic community, holding a 73rd percentile in Nursing Gerontology and a 59th percentile in Medicine Geriatrics and Gerontology according to Scopus metrics. Since its inception in 2011, the journal has aimed to foster innovation and disseminate pivotal research that addresses the complexities of aging populations. Researchers, healthcare professionals, and students interested in the intricacies of geriatric care will find a wealth of open-access resources that contribute significantly to enhancing practice and care methodologies in Canada and beyond. With its address located at 66 Martin St, Toronto, ON L9T 2R2, Canada, the journal stands as a vital resource for stakeholders in the geriatric field.

Geriatrie et Psychologie Neuropsychiatrie du Vieillissement is a pivotal academic journal dedicated to the multidisciplinary study of aging, encompassing the fields of geriatrics, neuropsychiatry, and psychological health in the elderly population. Published by JOHN LIBBEY EUROTEXT LTD, this journal fosters knowledge dissemination and innovation, contributing to the understanding of the complexities faced by aging individuals. With a broad scope that includes biological psychiatry and neuropsychology, it serves as a vital resource for researchers, healthcare professionals, and students engaged in geriatric medicine and mental health. Although currently classified in the Q4 category across various relevant medical and psychological disciplines, the journal addresses critical topics that are essential for enhancing quality of care and improving patient outcomes. Additionally, the journal is accessible via open access options, promoting wide-ranging readership and collaboration within the academic community. As the field continuously evolves, Geriatrie et Psychologie Neuropsychiatrie du Vieillissement remains commited to pushing the boundaries of research and practice in gerontology and neuropsychiatry.

Australian Prescriber is a distinguished open-access journal published by Therapeutic Guidelines Ltd, aiming to advance the field of pharmacology and medical prescriptions. Since its inception in 1994, this journal has been dedicated to disseminating essential findings and insights related to therapeutic guidelines and pharmaceutical care, making it an invaluable resource for healthcare professionals and researchers alike. With an ISSN of 0312-8008 and an E-ISSN of 1839-3942, it caters to an audience that values evidence-based medicine, empowering practitioners with knowledge to enhance clinical practice. The journal currently holds a Q2 ranking in the Pharmacology (medical) category and is recognized in the 51st percentile among its peers, reflecting its significant contributions to the medical field. Available from 1995 to 2024, this journal not only serves as an academic platform but also a critical discussion forum for professionals keen on improving pharmacological practices in Australia and beyond.

The Journal of Pharmaceutical Health Care and Sciences is a premier open access journal published by BMC that aims to advance the field of pharmaceutical sciences by providing high-quality research and comprehensive reviews across various domains including pharmacology, nursing, and healthcare. With an impact factor reflecting its relevance and rigor, the journal has established itself as a significant platform for disseminating knowledge since its inception in 2015. The journal is indexed in Scopus, currently holding a position in the Q3 quartile for medical pharmacology and Q2 quartile for nursing pharmacology, indicating its growing influence and reach in the scientific community. Based in the United Kingdom with a commitment to open access, the Journal of Pharmaceutical Health Care and Sciences ensures that all researchers, professionals, and students have free access to vital research that fosters innovation and improves healthcare outcomes worldwide. With a focus on collaborative and multidisciplinary approaches, the journal invites contributions that align with its objectives of enhancing health care delivery and pharmaceutical practices.